XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash Flows from Operating Activities:    
Net income $ 5,982,340 $ 5,128,650
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (4,821,632) (105,681)
Change in fair value of warrant liabilities (5,509,917) (9,381,750)
Change in fair value of convertible note 196,200
Change in deferred underwriting fee (271,687)
Offering costs allocated to warrants 575,278
Changes in current assets and current liabilities:    
Prepaid expenses 716,462 (837,139)
Accounts payable and accrued expenses 2,278,574 2,579,641
Net cash used in operating activities (1,429,660) (2,041,001)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account (345,000,000)
Net cash used in investing activities (345,000,000)
Cash Flows from Financing Activities:    
Proceeds from Initial Public Offering, net of underwriters’ discount 338,595,000
Proceeds from issuance of Private Placement Warrants 9,400,000
Proceeds from issuance of Convertible Promissory Note 1,225,000
Repayment of promissory note to related party (90,996)
Payments of offering costs (585,420)
Net cash provided by financing activities 1,225,000 347,318,584
Net Change in Cash (204,660) 277,583
Cash – Beginning 277,583
Cash – Ending 72,923 277,583
Supplemental disclosure of noncash financing activities:    
Initial value of Class A ordinary shares subject to possible redemption 345,000,000
Initial value of warrant liabilities 17,870,000
Deferred underwriters’ discount payable charged to additional paid-in capital 12,075,000
Accretion of Class A ordinary shares subject to possible redemption 4,927,313 28,950,644
Deferred offering costs paid under promissory note $ 90,996